Skip to main content

Clifford Chance

Clifford Chance
All
Briefings

Briefings

In this section

Federal Trade Commission Enacts Changes to Reporting Requirements under the HSR Act for the Transfer of Exclusive Patent Licenses in the Pharmaceutical Industry

7 November 2013

The U.S. Federal Trade Commission (FTC), with the concurrence of the Assistant Attorney General, Antitrust Division, Department of Justice (Antitrust Division) has amended the Premerger Notification Rules (Rules) promulgated under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (HSR Act) that apply to proposed acquisitions of exclusive patent rights by companies in the pharmaceutical industry. The amendments are due to become effective 30 days after publication in the Federal Register.

Download PDF
  • Share on Twitter
  • Share on LinkedIn
  • Share via email
Back to top

Toolkits & Client Log-in